Genomic sequencing identifies mutant ‘drivers’ of common brain tumor

Genomic sequencing identifies mutant 'drivers' of common brain tumor

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of meningiomas report scientists. Experimental drugs that inhibit these mutant gene pathways are in clinical trials and have shown promising activity. (Source: ScienceDaily Headlines)

MedWorm Sponsor Message: Have a look at The Cancer and Oncology Daily, the new cancer portal with all the latest cancer news and research powered by MedWorm, updated daily.

View Source